Association between metabolic syndrome and cancer
M Uzunlulu, O Telci Caklili, A Oguz - Annals of Nutrition and Metabolism, 2016 - karger.com
Growing data show the association of metabolic syndrome (MetS) or its components with
cancer development and cancer-related mortality. It is suggested that in MetS and cancer …
cancer development and cancer-related mortality. It is suggested that in MetS and cancer …
The tumor microenvironment and its contribution to tumor evolution toward metastasis
G Lorusso, C Rüegg - Histochemistry and cell biology, 2008 - Springer
Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and
survival through the activation of oncogenes and inactivation of tumor suppressor genes …
survival through the activation of oncogenes and inactivation of tumor suppressor genes …
IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesis
YJ Jung, JS Isaacs, S Lee, J Trepel… - The FASEB …, 2003 - Wiley Online Library
Growing evidence indicates that inflammation is a contributing factor leading to cancer
development. However, pathways involved in this progression are not well understood. To …
development. However, pathways involved in this progression are not well understood. To …
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
X Peng, Z Sun, P Kuang, J Chen - European Journal of Medicinal Chemistry, 2020 - Elsevier
Histone deacetylases (HDACs) are a class of enzymes that remove acetyl from the ε-N-
acetyl lysine of histones, allowing histones to wrap DNA more tightly. HDACs play an …
acetyl lysine of histones, allowing histones to wrap DNA more tightly. HDACs play an …
[HTML][HTML] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
Regulation of inflammation in cancer by dietary eicosanoids
H Yang, E Rothenberger, T Zhao, W Fan, A Kelly… - Pharmacology & …, 2023 - Elsevier
Background Cancer is a major burden of disease worldwide and increasing evidence shows
that inflammation contributes to cancer development and progression. Eicosanoids are …
that inflammation contributes to cancer development and progression. Eicosanoids are …
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer
HM Hesham, DS Lasheen… - Medicinal Research …, 2018 - Wiley Online Library
Recently, molecular hybridization paradigm became an interesting and smart way to defeat
the multifaceted cancer disease by a single molecular entity that acts via several …
the multifaceted cancer disease by a single molecular entity that acts via several …
Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications
Cellular signaling pathways involved in the maintenance of the equilibrium between cell
proliferation and apoptosis have emerged as rational targets that can be exploited in the …
proliferation and apoptosis have emerged as rational targets that can be exploited in the …
Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in …
K Rosenquist, J Wennerberg, EB Schildt… - Acta oto …, 2005 - Taylor & Francis
Conclusion. Our results show that average and poor oral hygiene and inadequate dental
status are independent risk factors for oral and oropharyngeal squamous cell carcinoma …
status are independent risk factors for oral and oropharyngeal squamous cell carcinoma …
[HTML][HTML] Squamous cell carcinoma–similarities and differences among anatomical sites
W Yan, II Wistuba, MR Emmert-Buck… - American journal of …, 2011 - ncbi.nlm.nih.gov
Squamous cell carcinoma (SCC) is an epithelial malignancy involving many anatomical
sites and is the most common cancer capable of metastatic spread. Development of early …
sites and is the most common cancer capable of metastatic spread. Development of early …